Ali̇ Ayhan
0000-0001-7155-9096
Publication & Citation Trends
Publications
470 total
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Cited by 325
OpenAlex
Fertility‐sparing approach to malignant ovarian germ cell tumors – Oncologic and obstetric outocome: A retrospective study
Cited by 3
Semantic Scholar
Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study. OA
Cited by 21
Semantic Scholar
Carrier screening programs for rare diseases in developed countries and the case of Turkey: A systematic review. OA
Cited by 7
Semantic Scholar
Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study OA
Cited by 14
Semantic Scholar
Evaluatıon of Four Cases of Fertility-Sparing Surgery in Cervical Sarcoma and Review of the Literature
Cited by 0
Semantic Scholar
Oncologic and obstetric outcomes of early‐stage epithelial ovarian cancer patients who underwent fertility‐sparing surgery: A retrospective study
Cited by 2
Semantic Scholar
The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
Cited by 5
Semantic Scholar
Research Topics
Endometrial and Cervical Cancer Treatments
(190)
Ovarian cancer diagnosis and treatment
(163)
Uterine Myomas and Treatments
(65)
Cervical Cancer and HPV Research
(64)
Endometriosis Research and Treatment
(57)
Affiliations
Gynecologic Oncology Group
Trakya University
Ankara University
Karadeniz Technical University
Merck (Germany)